Friday 6 November 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
- Revenue
- +18.8%
- EPS
- +225.6%
- Free cash flow
- +708.4%
- Total debt
- −48.1%
Quarter to September 2026, against a year earlier
99.54
1.17
+1.19%
Follow ALB
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 6.20% | 0.69% | (5.02%) | (8.73%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
— | 7 | 6 | 6 | |
| 3.10% | 0.35% | (2.49%) | (4.11%) | ||
ROIC |
3.55% | 1.46% | (0.88%) | (2.02%) | |
Return on Tangible Assets |
4.76% | 0.55% | (3.91%) | (6.26%) | |
Average Days of Receivables |
44.57 | 44.96 | 43.81 | 49.58 | |
Free Cash Flow per Share |
0.00 | 11.46 | 5.16 | 6.16 | |
Free Cash Flow |
— | 1,351.43 | 608.26 | 725.28 | |
Capital Expenditures |
— | (448.89) | (473.04) | (556.99) | |
| Other line items | |||||
Cash ROIC |
0.00% | 9.62% | 4.65% | 4.97% | |
Accounts Receivable Turnover |
7.73 | 7.35 | 7.49 | 6.13 | |
Accounts Payable Turnover |
0.00 | 4.56 | 4.84 | 4.82 | |
Inventory Turnover |
3.12 | 2.98 | 2.98 | 3.34 | |
Average Days of Payables |
0.00 | 90.47 | 76.06 | 74.53 | |
Days of Inventory on Hand |
111.39 | 112.28 | 109.71 | 96.21 | |
Tax Rate |
(0.54) | (1.41) | 0.65 | 0.28 | |
Research and Development Expense of Revenue |
0.54% | 0.64% | 0.85% | 1.00% | |
Selling, General and Administrative Expense of Revenue |
9.03% | 9.44% | 10.26% | 10.70% | |
Share Based Compensation of Revenue |
0.59% | 0.64% | 0.75% | 0.78% | |
Interest Coverage |
4.13 | 1.46 | (0.80) | (1.77) | |
Operating CF/Net income |
0.00 | 31.35 | (2.71) | (1.89) | |
Depreciation/Fixed assets |
0.08 | 0.10 | 0.10 | 0.10 | |
Capex/Depreciation |
0.00 | (0.55) | (0.57) | (0.66) | |
Revenue per Share |
52.14 | 50.08 | 46.62 | 43.71 | |
Operating CF per Share |
0.00 | 15.26 | 9.17 | 10.90 | |
Capex per Share |
0.00 | (3.81) | (4.01) | (4.73) | |
Capex to Sales |
0.00 | 0.08 | 0.09 | 0.11 |
Columns are period end dates · fundamentals updated 4 Nov 2026